Cortechs.ai | Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

San Diego, CA – Cortechs.ai, a global leader in AI-powered neuroimaging software, is proud to announce a strategic partnership with Kryptonite Solutions, a renowned provider of advanced MRI solutions. This collaboration will expand the distribution of Cortechs.ai’s innovative portfolio across India, enhancing access to cutting-edge neuroimaging technology for healthcare providers and patients alike.

The partnership brings together Kryptonite Solutions’ extensive distribution network and expertise in MRI patient comfort with Cortechs.ai’s industry-leading AI-driven imaging solutions. This synergy will help radiologists and neurologists across India leverage state-of-the-art software to improve diagnostic accuracy and patient outcomes.

“This partnership with Kryptonite Solutions marks a significant milestone in our mission to enhance neuroimaging capabilities worldwide,” said Kyle Frye, CEO of Cortechs.ai. “India is a rapidly growing healthcare market with an increasing demand for advanced imaging solutions. By collaborating with Kryptonite Solutions, we are ensuring that more healthcare providers can access and benefit from our AI-driven analysis tools, ultimately improving patient care.”

Kryptonite Solutions has built a strong reputation for delivering innovative MRI technologies that prioritize both patient experience and diagnostic efficiency. By integrating Cortechs.ai’s software into their offerings, Kryptonite Solutions aims to provide a more comprehensive imaging solution to hospitals and imaging centers across India.

“This collaboration unites two industry leaders in the medical imaging space, allowing us to bridge the gap between patient-centric MRI solutions and cutting-edge AI-driven diagnostics. Together, we are creating a more seamless and efficient imaging experience for hospitals and imaging centers worldwide,” said Paras Doshi, Founder and Managing Partner at Kryptonite Solutions.

Daniel D’Amour, Director of Global Partnerships at Cortechs.ai, also emphasized the strategic importance of this collaboration: “Kryptonite Solutions’ deep understanding of the Indian healthcare landscape and strong distribution network make them an ideal partner for us. This partnership will allow us to bridge the gap between AI-powered imaging and real-world clinical application, ensuring that patients across India benefit from the latest advancements in neuroimaging.”

By combining Kryptonite Solutions’ patient-centric approach with Cortechs.ai’s AI-driven expertise, this partnership aims to redefine how neurological conditions are diagnosed and managed in India. The collaboration represents a significant leap forward in providing healthcare professionals with the tools they need to make more informed and accurate diagnostic decisions.

For more information about Cortechs.ai and Kryptonite Solutions, visit https://www.cortechs.ai/ and https://kryptonite.global/.

 

About Cortechs.ai

Cortechs.ai is a leader in AI applications in radiology, leveraging advanced technologies in medical imaging to enhance disease screening and early detection, empowering healthcare providers to deliver better outcomes for patients. The company develops and markets innovative medical device software that quantifies and tracks neurodegeneration and prostate cancer, helping clinicians detect and monitor clinically significant cases. Cortechs.ai’s industry-leading imaging solutions offer radiologists, oncologists, and urologists a streamlined, cost-effective way to assess prostate health, including detection and monitoring of cancer. The company also has FDA-cleared products for use in assessing neurological disorders such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, tumors, and other brain abnormalities. For more information, please visit www.cortechs.ai and follow us on Twitter, LinkedIn, and Facebook.

 

For more information, please contact:

___________

info@cortechs.ai

+1 858 459 9700

More Resources

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.
Scroll to Top